Generics 42

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Erythromycin stearate manufacturers

42 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

42 products found

erythromycin stearate

Tablets 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722
This multinational pharmaceutical company focuses on improving global health through the development and manufacturing of a wide range of affordable pharmaceuticals and nutritional products. They specialize in producing tablets, capsules, pellets, soft gelatin capsules, and oral liquids. Key therapy areas include cardiovascular diseases, diabetes, and gastrointestinal disorders. They hold prominent GMP certifications, including ISO 9001:2015 and WHO GMP accreditations for facilities in multiple regions, including the EU, North America, and Asia. Their robust R&D department drives innovation, evident in their "Dispersion Technology" for enhanced drug absorption. The company actively participates in international conferences and sponsors research initiatives focused on combating priority diseases as identified by the World Health Organization.

erythromycin stearate

Tablets 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19540
This company is a pharmaceutical and nutraceutical manufacturer committed to ethical business practices and delivering high-quality products. They operate in both regulated and non-regulated markets, producing a range of Allopathic, Neutraceutical, Health food, and Pharmaceutical products. Their commitment to innovation and research drives the development of world-class formulations across key therapy areas. While specific product details and regions aren't provided, they emphasize adherence to Good Manufacturing Practices (GMP) and prioritize improving human healthcare through their products.

erythromycin stearate

Tablets 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472
This company is a manufacturer and exporter of pharmaceutical products with over two decades of experience. They operate across three manufacturing facilities in India, specializing in a wide range of dosage forms including tablets, capsules, liquids, injectables, topicals, and nasal sprays. Their product portfolio encompasses generic, branded, nutraceutical, over-the-counter (OTC), and herbal medicines. Key therapy areas are not explicitly mentioned. They adhere to stringent quality standards with ISO 9001:2008 certification. The company exports its products to numerous regions globally, including the EU, North America, Africa, and the Middle East.

Want to see all 42 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

ERYTHROMYCIN STEARATE

Erythromycin Stearate is an antibiotic. It treats and prevents a wide variety of bacterial infections. Erythromycin Stearate inhibits the growth of drug-resistant bacteria, maintains the effectiveness of Erythrocin Stearate Film-coated tablets and other antibacterial drugs. It should be used to treat or prevent infections that are proven strong susceptibility to this medicine. It is indicated in the treatment of mild to moderate degree Upper and lower respiratory tract infections caused by Streptococcus pyogenes or Streptococcus pneumonia or Haemophilus influenza. It also used to treat Listeriosis caused by Listeria monocytogenes, Respiratory tract infections caused by Mycoplasma pneumonia, mild to moderately severe Skin and skin structure infections caused by Streptococcus pyogenes or Staphylococcus aureus, whooping cough caused by Bordetella pertussis, Diphtheria, Erythrasma, Intestinal amebiasis, Acute Pelvic Inflammatory Disease. Erythromycin Stearate is sold as Erythrocin Stearate amongst others. Abbott Laboratories first filed for a patent in the 70s and was given the go-ahead in 1981. Since then the original patent has expired.

DOSAGE AND ADMINISTRATION

Erythromycin Stearate is sold as film-coated tablets. However, the efficacy is best, when the optimal serum levels of erythromycin are reached it is taken in the fasting state or immediately before meals. the initial adult dose is usually 250 mg, taken every 6 hours or 500 mg, taken every 12 hours. Dosage can be increased in the intervals of 4g. In treating children, the Age, weight, and severity of the infection determine the dosage. They are normally given 30 to 50 mg per kilo per day, in equally divided doses. For curing streptococcal infections of the upper respiratory tract the dosage is given for at least ten days. in treating Conjunctivitis of the Newborn Caused by Chlamydia trachomatis, the oral suspension of 50mg per kilo per day, in 4 divided doses for at least 2 weeks. In the treatment of Pneumonia of Infancy Caused by Chlamydia trachomatis, the dose is suspension taken 50 per kilo per day, in four divided doses for at least 3 weeks. For treating Urogenital Infections During Pregnancy Due to Chlamydia Trachomatis, a dose of 500 mg is taken orally every 8 hours on an empty stomach for at least 7 days.

The cost of ERYTHROMYCIN STEARATE

In the USA, the consumers have around $352 for a supply of 30 oral tablets of 250 mg. As with most critical medicines, this medicine made in developing countries by generic drug makers has reduced the end cost significantly. In India, consumers can buy 10 tablets for as low as USD 1.1.

How does Erythromycin Stearate Work?

Erythromycin binding 50S ribosomal subunits of susceptible organisms thus inhibiting protein synthesis. It creates resistance by modifying the 23S rRNA in the 50S ribosomal subunit. It causes insensitivity while efflux can is significant. Overall resulting in the prevention of bacterial protein synthesis. It may also have bacteriostatic or bactericidal actions in different concentrations at the site of infection and the susceptibility of the infecting organism.

Finding Erythromycin Stearate Manufacturers and Suppliers

The best way to find and gain access to Erythromycin Stearate manufacturers and Erythromycin Stearate suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Erythromycin Stearate can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Erythromycin Stearate to work with. You can fine-tune your search results using various filters too, letting you search for Erythromycin Stearate from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible